Janssen Sues Distributors Over Counterfeit Antiretroviral Therapies in the US
Johnson & Johnson’s (J&J; NYSE: JNJ) subsidiary, Janssen, filed a lawsuit last week against pharmaceutical...
Columbia University Study Weighs Cost-Effectiveness of Weight-Loss Treatments for Adolescents
Researchers at US Columbia University have published the results of a study estimating the cost-effectiveness...
Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations
China-based pharmaceutical distribution giant Shanghai Pharmaceuticals (SPH; HKG: 2607; SHA: 601607) has disclosed that several...
BDgene Technology Announces Clinical Milestone for CRISPR-Cas9 Gene Therapy in HSK
Gene therapy specialist Shanghai BDgene Technology Co., Ltd has announced the conclusion of three clinical...
Sanofi Announces Management Restructuring with New Leadership Roles in China
French pharmaceutical giant Sanofi (NASDAQ: SNY) has announced a significant restructuring of its management structure...
ImmuneOnco Biopharmaceuticals Begins Trading on HKEX with Successful IPO
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd (HKG: 1541) marked its debut on the Hong Kong Stock...
Sihuan Pharmaceutical’s Birociclib NDA Accepted for Review by China’s NMPA
China’s Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) has announced that the National Medical Products...
Bloomage Biotech Terminates Joint Venture with Medytox Inc. for Botulinum Toxin Development
China-based Bloomage Biotech (SHA: 688363) has revealed that a termination agreement has been signed with...
Jointown Medical’s COVID-19 Drug Candidate SHEN211 Accepted for Review by NMPA
China-based Jointown Medical Devices Group Co., Ltd (SHA: 600998) has announced that its clinical trial...
Hansoh Pharmaceutical Receives NMPA Approval for Generic Ofev (Nintedanib)
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has announced that it has received marketing...
Pilot Gene Technology Secures $13.8 Million in Series B Financing for Diagnostic Expansion
China-based diagnostic reagents specialist, Pilot Gene Technology (Hangzhou) Co., Ltd, has reportedly raised RMB 100...
Chia Tai Tianqing’s Generic Entresto Approved by NMPA, Launch Expected in 2026
The National Medical Products Administration (NMPA) website has indicated that Chia Tai Tianqing’s generic version...
Novo Nordisk’s Esperoct on Track for Priority Review in Hemophilia A Treatment
The Center for Drug Evaluation (CDE) website has indicated that Denmark-based Novo Nordisk’s (NYSE: NVO)...
Bayer Subsidiary’s Parkinson’s Treatment Bemdaneprocel Shows Promise in Phase I
Germany-based Bayer (ETR: BAYN) has announced that its subsidiary BlueRock Therapeutics’ open-label Phase I study...
AstraZeneca’s Calquence Approved by NMPA for Chronic Lymphocytic Leukemia Treatment
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) has announced that it has received another indication...
Roche’s Alecensa Achieves Milestone in Adjuvant Therapy Trial for Early-Stage NSCLC
Switzerland-based pharmaceutical giant Roche (SWX: ROG) has released an update from an interim analysis of...
Amgen and Horizon Therapeutics Reach Agreement with FTC to Proceed with Acquisition
Amgen (NASDAQ: AMGN) and Horizon Therapeutics (NASDAQ: HZNP) have announced a consent order agreement with...
Japan’s MHLW Reviews GSK’s Nucala for Chronic Rhinosinusitis with Nasal Polyps Indication
The Ministry of Health, Labour and Welfare (MHLW) in Japan has begun the review process...
Eli Lilly’s Verzenios Receives NMPA Approval for Extended Indication in Early-Stage Breast Cancer
US pharmaceutical major Eli Lilly & Co., (NYSE: LLY) has announced that the National Medical...
Shanghai Biotech Cataya Secures $35 Million in Series B Financing for Synthetic Biology
Shanghai-based biotech company Cataya, which specializes in synthetic biology, has reportedly raised RMB 250 million...